Acute impairment of renal function subsequent to the intravascular administration of contrast material
CIN is defined as a reported rise in serum creatinine of more than 25% above baseline or an absolute rise of 0.5 mg/dL within 48 hours of receiving an iodinated contrast agent
The serum creatinine level generally peaks at 4 to 5 days and then begins to return toward baseline within 7 to 10 days in CIN
Patients with CIN are usually nonoliguric and CIN is usually reversible
Urinalysis in CIN typically reveals coarse granular casts, renal tubular epithelial cells, and amorphoussediment. Proteinuria may be low grade. Hematuria is not a characteristic of CIN
In the random population undergoing contrast-enhanced imaging, the incidence of CIN is low, generally thought to be between 1% and 6%
Patients with diabetes mellitus and preexisting renal insufficiency represent a group with an extremely high risk of experiencing CIN
There is a direct correlation between the volume of contrast administered and risk of CIN
Dehydration before the imaging examination increases the risk of CIN
Multiple myeloma has traditionally been regarded as a risk factor for CIN, but the risk is primarily related to the dehydration of the multiple myeloma patient
High-osmolar contrast media (HOCM)
Associated with a higher rate of nephrotoxicity than low-osmolar contrast media (LOCM)
Hydration decreases the incidence of CIN
CIN is dependent on the dose of contrast material used
Medications like NSAIDs and dipyridamole are associated with the development of acute renal failure
Metformin
An oral medication given to non-insulin-dependent diabetics to lower blood sugar. It should be temporarily discontinued after any examination involving iodinated contrast and can be resumed after 2 days, assuming kidney function is normal
The half-life of iodinated contrast media in patients with normal renal function is approximately 2 hours, but in patients with severe renal dysfunction it can be extended to more than 30 hours
Thyroid storm
A severe, life-threatening condition resulting when thyroid hormone reaches a dangerously high level, which can be precipitated by iodinated contrast media
Iodinated contrast media can intensify thyroid toxicosis (excessive thyroid hormone) in patients with a history of hyperthyroidism
Iodine deficiency is an important factor in the development of thyroid autonomy
Potential pulmonary adverse effects of iodinated contrast agents include bronchospasm, pulmonary arterial hypertension, and pulmonary edema
Patients with a history of pulmonary hypertension, bronchial asthma, or heart failure are at increased risk of pulmonary adverse effects from iodinated contrast agents
The use of LOCM significantly reduces the risk of pulmonary effects from iodinated contrast agents